## Abstract Four decades after the first isolation and characterization of clonogenic bone marrow stromal cells or mesenchymal stem cells (MSC) in the laboratory of Dr. Alexander Friedenstien, the therapeutic application of their progeny following ex vivo expansion are only now starting to be reali
Therapeutic factors secreted by mesenchymal stromal cells and tissue repair
✍ Scribed by Ryang Hwa Lee; Joo Youn Oh; Hosoon Choi; Nikolay Bazhanov
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 278 KB
- Volume
- 112
- Category
- Article
- ISSN
- 0730-2312
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Systemic administration of MSCs resulted in remarkable functional improvements in injured tissues without either long‐term engraftment or differentiation in many clinical and experimental situations. Emerging evidence suggest that most of the beneficial effects of MSCs could be explained by secretion of soluble factors that have multiple effects including modulation of inflammatory and immune reactions, protection from cell death, and stimulation of endogenous progenitor cells. In this review, we focus on the therapeutic factors that account for the beneficial effects of MSCs in animal models of human diseases. J. Cell. Biochem. 112: 3073–3078, 2011. © 2011 Wiley Periodicals, Inc.
📜 SIMILAR VOLUMES
## Abstract ## Objective To identify the components of conditioned medium obtained from intervertebral disc nucleus pulposus–derived canine notochord cells, and to evaluate the capacity of such factors to affect disc‐derived chondrocyte gene expression of aggrecan, versican, and hyaluronic acid sy